Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

98.95

Jul 14 • 03:59PM ET +5.22 (5.57%)

100.64

Aftermarket • 06:57PM ET +1.69 (1.71%)

Healthcare Biotechnology USA Mid NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: IWM VTI XBI IWO VXF IBB SCHA VTWO VHT CGMM

Scroll to Statements

Index	RUT
Market Cap	8.59B
Enterprise Value	8.01B
Income	-168.74M
Sales	0.00M
Book/sh	6.53
Cash/sh	8.54
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	102
IPO	Apr 07, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	15.15
P/C	11.59
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.97
Current Ratio	8.97
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-2.36
EPS next Y	-3.21
EPS next Q	-0.76
EPS this Y	-52.10%
EPS next Y	-6.56%
EPS next 5Y	-23.61%
EPS past 3/5Y	57.01% 44.61%
Sales past 3/5Y	- -
EPS Y/Y TTM	22.31%
Sales Y/Y TTM	-
EPS Q/Q	-46.71%
Sales Q/Q	-
Earnings	May 05 BMO
EPS/Sales Surpr.	-11.18% -

Insider Own	10.82%
Insider Trans	-34.87%
Inst Own	82.69%
Inst Trans	-3.65%
ROA	-25.30%
ROE	-29.26%
ROIC	-25.15%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	8.44%
SMA50	22.67%
SMA200	110.43%
Trades

Shs Outstand	78.84M
Shs Float	77.45M
Short Float	17.61%
Short Ratio	9.65
Short Interest	13.64M
52W High	102.06 -3.05%
52W Low	14.51 582.18%
Volatility	5.83% 5.84%
ATR (14)	5.81
RSI (14)	63.74
Beta	3.04
Rel Volume	1.96
Avg Volume	1.41M
Volume	2,776,366

Perf Week	5.01%
Perf Month	22.51%
Perf Quarter	56.39%
Perf Half Y	223.26%
Perf YTD	202.05%
Perf Year	502.99%
Perf 3Y	608.05%
Perf 5Y	-43.54%
Perf 10Y	-14.88%
Recom	1.06
Target Price	103.93
Prev Close	93.73
Price	98.95
Change	5.57%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)